Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use

Early data from the CU programme show delamanid may be effective in MDR/XDR-TB with few treatment options http://ow.ly/tA6Y30cs2Yg

Detalles Bibliográficos
Autores principales: Hafkin, Jeffrey, Hittel, Norbert, Martin, Alexandra, Gupta, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898945/
https://www.ncbi.nlm.nih.gov/pubmed/28751415
http://dx.doi.org/10.1183/13993003.00311-2017
_version_ 1783314211640705024
author Hafkin, Jeffrey
Hittel, Norbert
Martin, Alexandra
Gupta, Rajesh
author_facet Hafkin, Jeffrey
Hittel, Norbert
Martin, Alexandra
Gupta, Rajesh
author_sort Hafkin, Jeffrey
collection PubMed
description Early data from the CU programme show delamanid may be effective in MDR/XDR-TB with few treatment options http://ow.ly/tA6Y30cs2Yg
format Online
Article
Text
id pubmed-5898945
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-58989452018-04-18 Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use Hafkin, Jeffrey Hittel, Norbert Martin, Alexandra Gupta, Rajesh Eur Respir J Agora Early data from the CU programme show delamanid may be effective in MDR/XDR-TB with few treatment options http://ow.ly/tA6Y30cs2Yg European Respiratory Society 2017-07-27 /pmc/articles/PMC5898945/ /pubmed/28751415 http://dx.doi.org/10.1183/13993003.00311-2017 Text en Copyright ©ERS 2017 http://creativecommons.org/licenses/by-nc/4.0/ This ERJ Open article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Agora
Hafkin, Jeffrey
Hittel, Norbert
Martin, Alexandra
Gupta, Rajesh
Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
title Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
title_full Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
title_fullStr Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
title_full_unstemmed Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
title_short Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
title_sort early outcomes in mdr-tb and xdr-tb patients treated with delamanid under compassionate use
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898945/
https://www.ncbi.nlm.nih.gov/pubmed/28751415
http://dx.doi.org/10.1183/13993003.00311-2017
work_keys_str_mv AT hafkinjeffrey earlyoutcomesinmdrtbandxdrtbpatientstreatedwithdelamanidundercompassionateuse
AT hittelnorbert earlyoutcomesinmdrtbandxdrtbpatientstreatedwithdelamanidundercompassionateuse
AT martinalexandra earlyoutcomesinmdrtbandxdrtbpatientstreatedwithdelamanidundercompassionateuse
AT guptarajesh earlyoutcomesinmdrtbandxdrtbpatientstreatedwithdelamanidundercompassionateuse

Ejemplares similares